Authors:
Blomenrohr, M
Heding, A
Sellar, R
Leurs, R
Bogerd, J
Eidne, KA
Willars, GB
Citation: M. Blomenrohr et al., Pivotal role for the cytoplasmic carboxyl-terminal tail of a nonmammalian gonadotropin-releasing hormone receptor in cell surface expression, ligand binding, and receptor phosphorylation and internalization, MOLEC PHARM, 56(6), 1999, pp. 1229-1237
Authors:
De Esch, IJP
Vollinga, RC
Goubitz, K
Schenk, H
Appelberg, U
Hacksell, U
Lemstra, S
Zuiderveld, OP
Hoffmann, M
Leurs, R
Menge, WMPB
Timmerman, H
Citation: Ijp. De Esch et al., Characterization of the binding site of the histamine H-3 receptor. 1. Various approaches to the synthesis of 2-(1H-imidazol-4-yl)cyclopropylamine and histaminergic activity of (1R,2R)- and (1S,2S)-2-(1H-imidazol-4-yl)cyclopropylamine, J MED CHEM, 42(7), 1999, pp. 1115-1122
Authors:
Tensen, CP
Flier, J
van der Raaij-Helmer, EMH
Sampat-Sardjoepersad, S
van der Schors, RC
Leurs, R
Scheper, RJ
Boorsma, DM
Willemze, R
Citation: Cp. Tensen et al., Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3), J INVES DER, 112(5), 1999, pp. 716-722
Authors:
Wieland, K
Ter Laak, AM
Smit, MJ
Kuhne, R
Timmerman, H
Leurs, R
Citation: K. Wieland et al., Mutational analysis of the antagonist-binding site of the histamine H-1 receptor, J BIOL CHEM, 274(42), 1999, pp. 29994-30000
Authors:
Hough, LB
Nalwalk, JW
Leurs, R
Menge, WMPB
Timmerman, H
Citation: Lb. Hough et al., Antinociceptive activity of impentamine, a histamine congener, after CNS administration, LIFE SCI, 64(5), 1998, pp. PL79-PL86